How will remanding Texas v. U.S. case to the lower court will affect the health care market? Drug manufacturers face tremendous scientific uncertainty while ACA funding has clearly become a major component in state spending.
Medicare and Medicaid
Other featured articles
Provider Charges Relative to Medicare Rates, 2012-2017
Researchers examined data on charges for providers treating Medicare patients and compared them to Medicare’s set payment rate across specialties. They found specialties possessing the ability to surprise bill out-of-network patients higher charges relative to Medicare rates than other specialties.
To Really Cut Health Spending, Put Pharmacists on the Front Line
Sixteen percent of all U.S. healthcare expenditures can be attributed to patients failing to properly adhere to their prescriptions. Pharmacists can be an important, and valuable, part of a patient’s care team.
Who Pays in Medicare Part D? Giving Plans More Skin in the Game
Private plans have the potential to lead the way toward innovative contracting approaches that emphasize value and, in doing so, deliver on the original vision for the Part D marketplace.
PODCAST: The Biggest Health Care Issues of the 2020 Election
In this episode of the Brookings Cafeteria podcast, health policy experts from the USC-Brookings Schaeffer Initiative discuss the presidential candidates’ health proposals, and also look at what to do about surprise medical billing.
About this section
The nation’s growing debt threatens Medicare and Medicaid, which have helped countless Americans and reduced poverty. Schaeffer Center researchers work with legislators on a bipartisan basis to bolster these vital systems, making them more efficient and effective.